Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Correction: The challenge of COVID-19 and hematopoietic cell transplantation: EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy

The Original Article was published on 13 May 2020

Correction to: Bone Marrow Transplantation

https://doi.org/10.1038/s41409-020-0919-0

The original HTML and PDF versions of this article were updated shortly after publication to correct author Bregje Verhoeven’s name and affiliation.

Bregje Verhoeven was incorrectly associated with Willem-Alexander Children’s Hospital, Department of Pediatrics, Leiden University Medical Center, Leiden, The Netherlands. The correct affiliation is Foundation Hematon, Utrecht, The Netherlands.

This has now been corrected in both the PDF and HTML versions of the article.

Author information

Affiliations

Authors

Consortia

Corresponding author

Correspondence to Per Ljungman.

Additional information

The original article can be found online at https://doi.org/10.1038/s41409-020-0919-0.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ljungman, P., Mikulska, M., de la Camara, R. et al. Correction: The challenge of COVID-19 and hematopoietic cell transplantation: EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy. Bone Marrow Transplant 56, 755 (2021). https://doi.org/10.1038/s41409-020-0965-7

Download citation

Search

Quick links